Pamuk G.E.Pamuk Ö.N.Tekgündüz E.Turgut B.Demir M.Çakir N.2024-06-122024-06-1220071306-133Xhttps://hdl.handle.net/20.500.14551/17747There are some data that the frequency of malignancy increases in some autoimmune diseases. The development of Hodgkin's lymphoma in patients with systemic lupus erythematosus (SLE) has been reported rarely. Here, we presented a young male SLE patient who had recurrent thrombophlebitis and deep venous thrombosis, secondary antiphospholipids syndrome, and who has been using cyclophosphamide and corticosteroids for 1.5 years for lupus nephritis. After a follow-up of 1.5 years, he developed fever, night sweats and lymphadenopathy. Lymph node biopsy was compatible with mixed-cellular type Hodgkin's lymphoma, and he was in complete hematologic remission after ABVD chemotherapy. Although SLE is a disease which may cause lymphadenopathy and B symptoms, when these symptoms develop in a SLE patient in remission, lymph node biopsy should be taken to rule out the possibility of lymphoma.trinfo:eu-repo/semantics/closedAccessHodgkin's Lymphoma; Lymphadenopathy; Secondary Antiphospholipid Syndrome; Systemic Lupus ErythematosusCorticosteroid; Cyclophosphamide; Antiphospholipid Syndrome; Article; Case Report; Deep Vein Thrombosis; Fever; Follow Up; Hematology; Hodgkin Disease; Human; Human Tissue; Lymph Node Biopsy; Lymphadenopathy; Male; Night Sweat; Recurrent Disease; Remission; Systemic Lupus Erythematosus; ThrombophlebitisArticle17137412-s2.0-34248153850Q4